Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection

急性和慢性感染中组织驻留记忆 T 细胞命运的分子决定因素

基本信息

  • 批准号:
    10453786
  • 负责人:
  • 金额:
    $ 192.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-17 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

OVERALL SUMMARY: Mortality from infectious diseases remains the second leading cause of death worldwide; a further toll on human health is exacted by disease-associated morbidity. The development of new vaccines is, therefore, an important priority for improving global health. Immunological memory is a cardinal feature of adaptive immunity and its induction is the underlying goal of vaccination. Long-lived memory T cells mediate protection from reinfection with previously encountered pathogens; keep chronic, opportunistic and latent pathogens at bay; and can serve as endogenous defenders against tumor growth and metastases. The memory T cell population is heterogeneous, typically categorized into central memory cells found in the blood and lymphoid tissues, or effector memory cells predominantly located in the blood and non-lymphoid tissues. The recent recognition of a third subset of memory lymphocytes, termed tissue-resident memory cells (Trm), that reside strictly within tissues and do not recirculate requires a revision of our understanding of memory T cell differentiation. Tissue- resident T cells provide essential sentinel protection at body surfaces such as the intestinal epithelium, and, are now clearly understood to be among the key `first responders' in many infection settings. Although we now know that resident-memory cells are an essential component of immune memory, little is known about the transcriptional pathways regulating their formation, survival and function. Improving our understanding of these topics will allow us to harness the immediate protective capacity of this vital memory T cell population and modulate activity in the context of immunopathology. To this end, we propose three synergistic projects that all leverage novel single-cell, genomic and computational analyses provided by two Cores to: 1) Define the unanticipated roles of key transcription factors in Trm formation and identify novel molecular determinants of Trm differentiation and homeostasis; 2) Identify early molecular regulators of Trm cell fate specification within different tissues in the context of acute and chronic infections using single-cell analyses of gene expression and computational approaches; 3) Define exhausted Trm during chronic viral infection and identify core regulators that determine their accumulation and hypo-functional state. Understanding the generation and homeostasis of tissue-resident memory cells will allow the exploitation of the immediate protective capacity of this vital memory population and provide strategies to modulate this activity in the context of immunopathology. We have assembled a team of five laboratories, which together possess the tools and expertise to resolve the transcriptional network driving memory T cell formation and exploit this knowledge to realize advances in regulating immunity in tissues. !
总体总结: 传染病死亡率仍然是世界范围内第二大死亡原因; 人类健康是由疾病引起的发病率决定的。因此,新疫苗的开发是一项 改善全球健康的重要优先事项。免疫记忆是适应性免疫的一个重要特征 并且其诱导是疫苗接种的根本目标。长寿命记忆T细胞介导的保护, 再次感染以前遇到的病原体;防止慢性、机会性和潜伏病原体; 并且可以作为抗肿瘤生长和转移的内源性防御者。记忆T细胞群 是异质的,通常分类为血液和淋巴组织中发现的中央记忆细胞,或 效应记忆细胞主要位于血液和非淋巴组织中。最近,A 记忆淋巴细胞的第三个子集,称为组织驻留记忆细胞(Trm),严格居住在 组织和不再循环需要我们的记忆T细胞分化的理解修订。组织- 驻留T细胞在体表如肠上皮提供必需的前哨保护,并且, 现已清楚地认识到,在许多感染情况下,这些人是关键的“第一反应者”。尽管我们现在 虽然我们知道驻留记忆细胞是免疫记忆的重要组成部分,但对它们的作用却知之甚少。 转录途径调节它们的形成、存活和功能。 提高我们对这些主题的理解将使我们能够利用这种直接的保护能力, 在免疫病理学的背景下,重要的记忆T细胞群和调节活性。为此我们 我提出了三个协同项目,都利用新的单细胞,基因组和计算分析 由两个核心提供:1)定义关键转录因子在Trm形成中的意外作用, 鉴定Trm分化和稳态新分子决定因素; 2)鉴定早期分子 急性和慢性感染背景下不同组织中Trm细胞命运特化的调节因子 使用基因表达的单细胞分析和计算方法; 3)在 慢性病毒感染,并确定决定其积累和功能减退状态的核心调节因子。 了解组织驻留记忆细胞的产生和稳态将允许利用组织驻留记忆细胞。 立即保护能力,并提供策略来调节这种活动, 免疫病理学的背景。我们组建了一个由五个实验室组成的团队,他们共同拥有 工具和专业知识来解决驱动记忆T细胞形成的转录网络,并利用这一点 知识,以实现在调节免疫组织的进展。!

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Systems-level identification of key transcription factors in immune cell specification.
  • DOI:
    10.1371/journal.pcbi.1010116
  • 发表时间:
    2022-09
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ananda W Goldrath其他文献

Ananda W Goldrath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ananda W Goldrath', 18)}}的其他基金

Ubiquitin ligase regulation of tissue-resident T cell and anti-tumor activity
泛素连接酶对组织驻留 T 细胞的调节和抗肿瘤活性
  • 批准号:
    10726015
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
  • 批准号:
    10683278
  • 财政年份:
    2020
  • 资助金额:
    $ 192.62万
  • 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
  • 批准号:
    10591871
  • 财政年份:
    2020
  • 资助金额:
    $ 192.62万
  • 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
  • 批准号:
    10024589
  • 财政年份:
    2020
  • 资助金额:
    $ 192.62万
  • 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
  • 批准号:
    10224894
  • 财政年份:
    2020
  • 资助金额:
    $ 192.62万
  • 项目类别:
Regulation of memory T cell differentiation and long-term maintenance
记忆T细胞分化和长期维持的调节
  • 批准号:
    10488590
  • 财政年份:
    2020
  • 资助金额:
    $ 192.62万
  • 项目类别:
Project 1 - Goldrath
项目1-戈德拉思
  • 批准号:
    10214455
  • 财政年份:
    2018
  • 资助金额:
    $ 192.62万
  • 项目类别:
Project 1 - Goldrath
项目1-戈德拉思
  • 批准号:
    10453791
  • 财政年份:
    2018
  • 资助金额:
    $ 192.62万
  • 项目类别:
Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
急性和慢性感染中组织驻留记忆 T 细胞命运的分子决定因素
  • 批准号:
    10214451
  • 财政年份:
    2018
  • 资助金额:
    $ 192.62万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10453787
  • 财政年份:
    2018
  • 资助金额:
    $ 192.62万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 192.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了